Evaluating the Therapeutic Effects of Cannflavins on Hippocampal Neuronal Systems Function in the Valproic Acid Model of Autism Spectrum Disorder
Year: 2023
Type: dissertation
Abstract: Autism spectrum disorders (ASD) show significant variability in symptom presentation. No pharmacological therapies exist to treat the core symptoms. There is widespread interest in cannabis as a therapy in ASD, yet the therapeutic potential of select cannabis constituents has not been explored. Here, the effects of cannflavin A or cannflavin B on hippocampal (HIP) neuronal morphology, activity and cell death in vitro were evaluated using the valproic acid (VPA) idiopathic rat model of ASD. HIP primary cultures were treated sub-chronically, every 3 days, with cannflavin A, cannflavin B (1nM), or vehicle. Cannflavin B increased dendritic branching in male, but not female, VPA-derived HIP cultures. Pre-and post-treatment neuronal activity recordings revealed that cannflavin A and cannflavin B normalized VPA-induced alterations in activity with sex-dependent effects. These in vitro findings indicate therapeutic potential for cannflavins in ASD, although further in vivo studies are required.
Author: Coppolino, Madeleine
Institution: University of Guelph
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7212459125
